INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

13 فبراير 2025 10:53:03 بحسب NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

13 يناير 2025 09:45:33 بحسب NetDania Notify

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

13 يناير 2025 06:32:27 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

10 يناير 2025 09:47:51 بحسب NetDania Notify

Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz 

10 يناير 2025 06:30:00 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 يناير 2025 08:00:11 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

11 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy

03 ديسمبر 2024 07:30:38 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

19 نوفمبر 2024 08:00:53 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

11 نوفمبر 2024 09:45:08 بحسب NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

07 نوفمبر 2024 09:48:04 بحسب NetDania Notify

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

07 نوفمبر 2024 08:00:18 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

06 نوفمبر 2024 09:45:14 بحسب NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

05 نوفمبر 2024 15:06:30 بحسب NetDania Notify

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

05 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

30 أكتوبر 2024 09:50:43 بحسب NetDania Notify

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

30 أكتوبر 2024 07:30:35 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

17 أكتوبر 2024 08:00:33 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

23 سبتمبر 2024 08:00:34 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

28 أغسطس 2024 08:00:04 بحسب Nasdaq GlobeNewswire